Evidence map›Paper›PMID 32593509›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2020

Fibrocyte accumulation in the lungs of cystic fibrosis patients.

Rajesh K Kasam, Prathibha R Gajjala, Anil G Jegga, Jennifer A Courtney, Scott H Randell, Elizabeth L Kramer, John P Clancy, Satish K Madala

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia.American journal of physiology. Lung cellular and molecular physiology · 2021
    Trial
  2. Review
  3. Mechanisms of prostatic inflammation-mediated male lower urinary tract symptoms.American journal of clinical and experimental urology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Rajesh K KasamDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Divisions of Pulmonary Medicine.
Prathibha R GajjalaDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Divisions of Pulmonary Medicine.
Anil G JeggaDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Bioinformatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229 USA.
Jennifer A CourtneyMolecular and Developmental Biology Graduate Program, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, 45229.
Scott H RandellDepartment of Cell Biology & Physiology, The University of North Carolina at Chapel Hill, North Carolina, 27599 USA.
Elizabeth L KramerDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Divisions of Pulmonary Medicine.
John P ClancyCystic Fibrosis Foundataion, Bethesda, Maryland, 20814 USA.
Satish K MadalaDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH; Divisions of Pulmonary Medicine. Electronic address: satish.madala@cchmc.org.
Pulmonary Associates · USUniversity of Cincinnati Medical Center · USCincinnati Children's Hospital Medical Center · USCystic Fibrosis Foundation · USUniversity of North Carolina at Chapel Hill · US

Funding

Vector CoreP30DK065988 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Martina Gentzsch · 2004 to 2026
$26.5M
WT1 REGULATION OF PULMONARY FIBROSISR01HL134801 · NHLBI · UNIVERSITY OF CINCINNATI · PI MADALA, SATISH K · 2017 to 2025
$3.9M
IL-31 Regulation of Immunopathology in Pulmonary FibrosisR21AG059533 · NIA · CINCINNATI CHILDRENS HOSP MED CTR · PI MADALA, SATISH K · 2018 to 2019
$452k
NHLBI NIH HHS R01 HL134801NIA NIH HHS R21 AG059533NIDDK NIH HHS P30 DK065988
6 · The paper itself

Abstract

backgroundCystic fibrosis (CF) patients develop severe lung disease including chronic airway infections, neutrophilic inflammation, and progressive fibrotic remodeling in airways. However, cellular and molecular processes that regulate excessive collagen deposition in airways in these patients remain unclear. Fibrocytes are bone marrow (BM)-derived mesenchymal cells that express the hematopoietic cell marker CD45, and mesenchymal cell markers and implicated in collagen deposition in several fibrotic diseases. It is unknown whether fibrocytes accumulate in the lungs of CF patients, so the current study evaluates the presence of fibrocytes in the fibrotic lesions of airways in explanted CF lungs compared to non-CF unused donor lungs (control).

methodsWe used immunofluorescence staining to determine if fibrocytes accumulate in explanted CF lungs compared to healthy donor lungs. Simultaneously, we evaluated cells collected by bronchoalveolar lavage (BAL) in CF patients using multi-color flow cytometry. Finally, we analyzed transcripts differentially expressed in fibrocytes isolated from the explanted CF lungs compared to control to assess fibrocyte-specific pro-fibrotic gene networks.

resultsOur findings demonstrate fibrocyte accumulation in CF lungs compared to non-CF lungs. Additionally, fibrocytes were detected in the BAL of all CF children. Transcriptomic analysis of fibrocytes identified dysregulated genes associated with fibrotic remodeling in CF lungs.

conclusionsWith significantly increased fibrocytes that show increased expression of pro-fibrotic gene transcripts compared to control, our findings suggest an intervention for fibrotic remodeling as a potential therapeutic target in CF.

Indexed as

AdolescentCase-Control StudiesCell Culture TechniquesChildChild, PreschoolCystic FibrosisFemaleHumansLeukocyte Common AntigensLungMaleMesenchymal Stem CellsLeukocyte Common AntigensPTPRC protein, humanCFTRCystic fibrosisFibrocytesLungPulmonary fibrosis

Identifiers

PMID32593509
PMCPMC7492481
OpenAlexW3037749402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.